Is India Leading the Global Biotechnology Sector with 21 Bio-Companies?
Click to start listening
Synopsis
India's biotechnology sector is booming, with Union Minister Dr. Jitendra Singh revealing that the nation now boasts 21 out of 121 global bio-companies. This achievement marks a pivotal moment in establishing India as a leader in biomanufacturing and biotechnology-driven growth, with ambitious plans for the future.
Key Takeaways
- India has 21 out of 121 global bio-companies.
- Bioeconomy aims to reach $300 billion.
- Biotech startups have surged to over 13,000.
- High-Performance Biomanufacturing Platforms launched.
- Focus on self-reliance in biotechnology.
New Delhi, Sep 1 (NationPress) In a significant move to establish India as a global hub for biotechnology-driven growth, Union Minister of State (Independent Charge) for Science and Technology Dr. Jitendra Singh announced on Monday that the nation now represents 21 out of the 121 bio-companies worldwide.
During an interactive session hosted by the Department of Biotechnology (DBT) and BIRAC with industry stakeholders at the India International Centre, Singh remarked: “This achievement is monumental for a nation that once trailed behind; today, we are at the forefront of institutionalizing biomanufacturing policy.”
At the meeting, Singh also unveiled the High-Performance Biomanufacturing Platforms under the BioE3 (Biotechnology for Economy, Environment, and Employment) Policy.
The newly introduced platforms unite 21 advanced bio-enabler facilities across the nation.
These facilities will provide shared infrastructure for startups, small and medium enterprises, industries, and academic institutions to test, scale, and commercialize technologies. The work encompasses microbial biomanufacturing, smart proteins, sustainable agriculture, functional foods, carbon capture, marine biotechnology, and next-generation cell and gene therapies.
Emphasizing India's recent advancements, the Minister highlighted that the country's bioeconomy has escalated from approximately $10 billion to nearly $100 billion today, aiming for a target of $300 billion in the forthcoming years.
He also pointed out the growth of biotech startups, which have surged from just 50 a decade ago to over 13,000 today, supported by nearly 100 incubators under BIRAC.
“We are leading the way in institutionalizing biomanufacturing policy,” Singh added.
The Minister affirmed that the government's emphasis on biomanufacturing aligns with a broader vision to make India self-sufficient in critical sectors and lessen reliance on imports.
“Bio-enablers are the cornerstone of India's next wave of biotechnology-led growth. By offering top-tier platforms, tools, and infrastructure, bio-enablers equip our scientists, startups, and industries to transition swiftly from ideas to innovations, and from laboratories to markets,” he said.
Point of View
It is crucial to recognize the potential impact on the nation's economy and self-reliance. The government’s initiatives reflect a commitment to fostering innovation and supporting startups, positioning India as a formidable player in the global biotechnology arena. This growth not only enhances India's scientific capabilities but also promises to improve the overall well-being of its citizens.
NationPress
01/09/2025
Frequently Asked Questions
How many bio-companies does India currently have?
India currently has 21 bio-companies out of a total of 121 globally.
What is the target for India's bioeconomy?
India aims to grow its bioeconomy from nearly $100 billion to $300 billion in the coming years.
What initiatives were launched by Dr. Jitendra Singh?
Dr. Jitendra Singh launched the High-Performance Biomanufacturing Platforms under the BioE3 Policy.
How has the number of biotech startups changed in India?
The number of biotech startups in India has increased from 50 a decade ago to over 13,000 today.
What is the significance of bio-enablers in India's biotechnology growth?
Bio-enablers provide essential infrastructure and support, allowing scientists and startups to accelerate the transition from ideas to market-ready innovations.
